Gene · 57104
Papers3,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of HILPDA in Diseases: Mechanisms and Functional Insights. | J Lipid Res | 2026 | 42810643 | PubTator, text mining | PubMed |
| Altered Lipolytic Protein Expression in Tumor-Associated Adipose Tissue Correlates with Aggressive Breast Cancer Features. | Cancers (Basel) | 2026 | 42794967 | PubTator, text mining | PubMed |
| ACOX1 downregulation contributes to macrophage M1 polarization and neutrophilic airway inflammation in asthma. | Int Immunopharmacol | 2026 | 42772039 | PubTator, text mining | PubMed |
| Delving into the clinical and genetic spectrum of NLSDM: A case study. | J Neuromuscul Dis | 2026 | 42765452 | PubTator, text mining | PubMed |
| Bovine viral diarrhea virus (BVDV) relies on cellular lipid droplet biogenesis and lipolysis to provide energy for viral replication. | Vet Res | 2026 | 42763408 | PubTator, text mining | PubMed |
| Defensive lipid droplets are PUFA reservoirs and suppliers driving bacterial clearance and inflammation. | Cell Rep | 2026 | 42747966 | PubTator, text mining | PubMed |
| Lipidomic Remodeling by HILPDA in Granulosa Cells Impairs Ovarian Reserve Through Disruption of Mitochondrial and Endoplasmic Reticulum Homeostasis. | FASEB J | 2026 | 42725586 | PubTator, text mining | PubMed |
| From physiological homeostasis to pathological injury: Cell-specific functions, imbalance mechanisms, and disease biomarker value of brain lipid droplets. | Int Immunopharmacol | 2026 | 42721506 | PubTator, text mining | PubMed |
| Androgen-Driven Dysregulation of Lipolysis in Cumulus Cells: Molecular Evidence and Metabolic Implications in Polycystic Ovary Syndrome. | Reprod Med Biol | 2026 | 42682701 | PubTator, text mining | PubMed |
| Liquiritigenin Ameliorates High-Fat Diet-Induced Hepatic Steatosis by Promoting Lipid Droplet Catabolism via PLIN2-ATGL Regulation. | Phytother Res | 2026 | 42675379 | PubTator, text mining | PubMed |
| Recent advances in adult-onset disorders of muscle lipid metabolism. | Curr Opin Neurol | 2026 | 42656071 | PubTator, text mining | PubMed |
| Expression and positive impact of omentin-1 on in vitro porcine oocyte maturation via the ERK1/2 and PRKAA1. | Reproduction | 2026 | 42640570 | PubTator, text mining | PubMed |
| DABPU-DE targeting host adipose triglyceride lipase provides broad-spectrum anti-coronavirus effects in vitro. | Front Pharmacol | 2026 | 42602407 | PubTator, text mining | PubMed |
| In vitro Modeling of Adipogenesis Using Mesenchymal Stem Cells from Subcutaneous Adipose Tissue to Explore the Cellular and Molecular Mechanisms Underlying Pediatric Obesity and Obesogenic Memory. | Obes Facts | 2026 | 42599843 | PubTator, text mining | PubMed |
| HILPDA Repression Induces Methuosis in Breast and Liver Cancer Cells by Dysregulating Lipid Metabolism. | Biofactors | 2026 | 42595722 | PubTator, text mining | PubMed |
| Substrate-Selective Lipolysis Facilitates Unsaturated TAG Accumulation in Obesity. | Diabetes | 2026 | 42579480 | PubTator, text mining | PubMed |
| Cold exposure aggravates vein occlusion through non-shivering thermogenesis-induced thrombocytopoiesis. | Cell Res | 2026 | 42533097 | PubTator, text mining | PubMed |
| Adipose triglyceride lipase driven lipolysis as a targetable metabolic vulnerability in prostate cancer with intrinsic metabolic inflexibility. | Br J Cancer | 2026 | 42493599 | PubTator, text mining | PubMed |
| Mechanistic insights into the role of PEDF-R (PNPLA2) in photoreceptors. | Biosci Rep | 2026 | 42423603 | PubTator, text mining | PubMed |
| PLIN1 restoration modulates lipid reprogramming and impedes tumor growth in ovarian cancer. | BMC Cancer | 2026 | 42414938 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57104/papers